CA
CRMD icon

Cornerstone Advisory’s CorMedix CRMD Stock Holding History

Cornerstone Advisory’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5
Closed – – 324
2021
Q4 		$0 Buy
+5
New +$25 ﹤0.01% 803

Other funds holding CRMD

Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cornerstone Advisory's CRMD Position: Q1 2022 in Review

Cornerstone Advisory sold out of CorMedix (CRMD) in Q1 2022, closing a stake of 5 shares.

Cornerstone Advisory first reported a position in CRMD in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 85 funds tracked by Wall St. Rank hold CRMD as of Q1 2022.

  • Cornerstone Advisory reported no remaining CorMedix position as of Q1 2022 after selling out during the quarter.
  • Cornerstone Advisory sold 5 CorMedix shares in Q1 2022.
  • Cornerstone Advisory first reported a position in CorMedix in Q4 2021 and held it in 1 quarter.
  • Cornerstone Advisory's CorMedix position peaked at $0 in Q4 2021.
  • 85 funds tracked by Wall St. Rank held CorMedix as of Q1 2022.

Based on Cornerstone Advisory's 13F filing for Q1 2022, filed 20 May 2022.